| Title: |
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria |
| Authors: |
Schrezenmeier, HubertAff1, Aff2, IDs00277023054830_cor1; Kulasekararaj, AustinAff3; Mitchell, LindsayAff4; de Latour, Régis PeffaultAff5; Devos, TimothyAff6, Aff7; Okamoto, ShinichiroAff8; Wells, RichardAff9; Popoff, EvanAff10; Cheung, AntoinetteAff10; Wang, AliceAff11; Tomazos, IoannisAff11; Patel, YogeshAff11; Lee, Jong WookAff12 |
| Source: |
Annals of Hematology. 103(1):5-15 |
| Database: |
Springer Nature Journals |